Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Semaglutide first gained FDA approval as a treatment for type 2 diabetes
Compounding includes the combining of two or more drugs. Semaglutide, a type of drug called a GLP-1 agonist, is FDA-approved as Ozempic and Rybelsus to treat type 2 diabetes and as Wegovy to treat overweight and obesity
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
While short-term use is generally safe , long-term safety is still being studied
US$ 20.68
US$ 25.15
US$ 29.75
US$ 20.94
US$ 24.56
US$ 29.52
US$ 29.65
US$ 24.10
US$ 27.06
US$ 25.71
